GLORIA PHARMA.
0024372.850.35% ( +0.01 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: GLORIA PHARMA.(002437) the Revenue is 539.11 M (-2.2%);the EBIT is 75.96 M (+21.69%);the EPS is 0.0425 (+59.77%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.54B2.20%
----
----
EBIT
0.08B21.69%
----
----
EPS
0.042559.77%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf